Debut Plus

₹825.1

▼ -14.61 -1.74%

18 Jul 2026

NSE Listed · Pharmaceuticals

Alembic Pharma Ltd. (APLLTD)

Volume: 6,502Avg Vol 1W: 37,883Avg Vol 1M: 74,52652W Range:₹635.8₹1,044
NSE BSE www.alembicpharmaceuticals.com
Key Ratios
Checked just now
Market Cap₹16,218 Cr
Current Price₹825.1
Previous Close₹839.71
High / Low (52w)₹1,044 / ₹635.8
Volume6,502
Avg Vol (1W)37,883
Avg Vol (1M)74,526
Stock P/E80.03
Book Value₹288.7
Dividend Yield1.45%
ROE11.89%
ROA7.66%
Revenue (TTM)—
Revenue Growth7.12%
Profit Margin9.19%
Total Debt₹0 Cr
Shares Outstanding20 Cr
Face Value₹2
EPS (TTM)₹37.18
P/B2.86
Debt / Equity0.25
50 DMA₹799.45
200 DMA₹747.95
Day change-1.74%
Price Chart
₹825.1▼ 8.84% · 1Y
₹951₹6469.2L
2025-11-25
2026-07-17

20-day avg volume: 74K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 10% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 80.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹1,562 Cr₹1,648 Cr₹1,693 Cr₹1,770 Cr₹1,711 Cr₹1,910 Cr₹1,876 Cr₹1,848 Cr
EBITDA₹170 Cr₹186 Cr₹200 Cr₹217 Cr₹214 Cr₹247 Cr₹229 Cr₹165 Cr
Net Profit₹135 Cr₹153 Cr₹138 Cr₹157 Cr₹154 Cr₹185 Cr₹133 Cr₹203 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹3,944 Cr₹4,611 Cr₹5,480 Cr₹5,356 Cr₹5,655 Cr₹6,257 Cr₹6,715 Cr₹7,399 Cr
EBITDA₹768 Cr₹1,071 Cr₹1,384 Cr₹638 Cr₹436 Cr₹689 Cr₹772 Cr₹854 Cr
Net Profit₹584 Cr₹829 Cr₹1,147 Cr₹521 Cr₹342 Cr₹616 Cr₹583 Cr₹675 Cr
EPS3143.9759.1826.517.431.3329.6834.33
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹4,778 Cr₹5,989 Cr₹6,709 Cr₹7,122 Cr₹6,183 Cr₹6,446 Cr₹7,773 Cr₹8,763 Cr
Total Liabilities₹2,060 Cr₹2,799 Cr₹1,642 Cr₹1,884 Cr₹1,812 Cr₹1,627 Cr₹2,583 Cr₹3,094 Cr
Equity₹2,718 Cr₹3,190 Cr₹5,067 Cr₹5,238 Cr₹4,370 Cr₹4,818 Cr₹5,190 Cr₹5,669 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹978 Cr₹685 Cr₹1,709 Cr₹676 Cr₹785 Cr₹823 Cr₹159 Cr₹886 Cr
Investing₹-756 Cr₹-732 Cr₹-839 Cr₹-372 Cr₹-448 Cr₹-321 Cr₹-568 Cr₹-506 Cr
Financing₹59 Cr₹155 Cr₹-597 Cr₹-217 Cr₹-262 Cr₹-438 Cr₹444 Cr₹-164 Cr
Free Cash Flow₹978 Cr₹685 Cr₹1,709 Cr₹676 Cr₹785 Cr₹823 Cr₹159 Cr₹886 Cr
Shareholding
Promoter 69.87% Institutions 20.12% Public 10.01%
Efficiency & Working Capital
ROCE10.8%
Interest Coverage8.4
Dividend Payout—
Debtor Days73 d
Inventory Days125 d
Payable Days41 d
Cash Conversion Cycle156 d
Working Capital Days198 d
Shareholding Details

As of 2026-06-30

Promoter69.9%
FII4.2%
DII15.9%
Institutions20.1%
Public10%
Promoter Pledge0%
No. of Shareholders86,796
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters69.6%69.6%69.6%69.6%69.6%69.6%69.7%69.7%69.7%69.7%69.7%69.9%
FIIs4.5%4.5%4.5%4.3%3.9%4.2%3.9%4%4%4.2%4.3%4.2%
DIIs13.9%14.5%15.4%15.5%16.1%16.1%16.4%16.5%16.3%16.2%16.2%15.9%
Public12%11.4%10.5%10.6%10.4%10.2%10%9.9%9.9%9.9%9.8%10%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders89,55285,21276,56774,82991,42993,94491,33689,01389,96987,00086,43286,796
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Nirayu Private LimitedShareholding of Promoter and Promoter Group35.8%7.03 Cr
Alembic LimitedShareholding of Promoter and Promoter Group28.5%5.61 Cr
Life Insurance Corporation Of IndiaPublic Shareholding4.3%84,95,125
Dsp Small Cap FundPublic Shareholding3.9%75,85,888
Chirayu Ramanbhai AminShareholding of Promoter and Promoter Group2.1%41,92,529
Kotak Small Cap FundPublic Shareholding1.7%34,27,766
Malika Chirayu AminShareholding of Promoter and Promoter Group1.5%30,05,730
Icici Prudential Pharma Healthcare And Diaganostics (p.h.d) FundPublic Shareholding1.4%27,12,515
Tata Aia Life Insurance Co Ltd Unit Linked Multi Cap FundPublic Shareholding1.2%22,64,405
Udit Chirayu AminShareholding of Promoter and Promoter Group0.5%10,06,980
Pranav Chirayu AminShareholding of Promoter and Promoter Group0.5%10,09,800
Shaunak Chirayu AminShareholding of Promoter and Promoter Group0.5%10,06,980
Chirayu Ramanbhai Amin HufShareholding of Promoter and Promoter Group0.1%2,18,295
Gallup Trust (pranav Chirayu Amin)Shareholding of Promoter and Promoter Group0.1%1,00,100
Inaaya Shaunak AminShareholding of Promoter and Promoter Group0%80,000
Naintara Shaunak AminShareholding of Promoter and Promoter Group0%80,000
Barkha Pranav AminShareholding of Promoter and Promoter Group0%50,100
Krupa Shaunak AminShareholding of Promoter and Promoter Group0%50,100
Satori Trust (chirayu Ramanbhai Amin)Shareholding of Promoter and Promoter Group0%50,100
Ranvir Pranav AminShareholding of Promoter and Promoter Group0%30,000
Samira Pranav AminShareholding of Promoter and Promoter Group0%30,000
Paushak LimitedShareholding of Promoter and Promoter Group0%855
Alembic City LimitedShareholding of Promoter and Promoter Group0%100
Shreno Publications LimitedShareholding of Promoter and Promoter Group0%100
Shreno Engineering LimitedShareholding of Promoter and Promoter Group0%100
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Chirayu Ramanbhai Amin00%2026-06-30
Malika Chirayu Amin00%2026-06-30
Pranav Chirayu Amin00%2026-06-30
Shaunak Chirayu Amin00%2026-06-30
Inaaya Shaunak Amin00%2026-06-30
Naintara Shaunak Amin00%2026-06-30
Barkha Pranav Amin00%2026-06-30
Krupa Shaunak Amin00%2026-06-30
Ranvir Pranav Amin00%2026-06-30
Samira Pranav Amin00%2026-06-30
Chirayu Ramanbhai Amin Huf00%2026-06-30
Alembic Limited00%2026-06-30
Board of Directors
NameDesignationYear
Chirayu R AminChairman & Chief Executive Officer2025
Rajkumar BahetiDirector (Finance) & Chief Financial Officer2025
Pranav AminManaging Director2025
Shaunak AminManaging Director2025
Ashok BaratIndependent Director2025
Manisha SarafCompany Sec. & Compli. Officer2025
Jai S DiwanjiIndependent Director2025
Manish KejriwalIndependent Director2025
Geeta GoradiaIndependent Director2025
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹2413939
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-29Dividend (12/- per share)Final
dividend2025-07-29₹11 (550%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202650600684451,023
202645100021472
2026410068423537
Insider / Designated-Person Trades

30 recent disclosure(s)

Nirayu Private LimitedAcquisition · 3,278
Nirayu Private LimitedAcquisition · 24,832
Nirayu Private LimitedAcquisition · 75,000
Nirayu Private LimitedAcquisition · 20,000
Nirayu Private LimitedAcquisition · 78,000
Nirayu Private LimitedAcquisition · 60,000
Substantial Acquisitions (SAST)

1 disclosure(s)

Market24/11/2023 · 36,276
Company Information
Incorporated2010
ChairmanChirayu R Amin
AuditorKKC & Associates LLP
Investor Email[email protected]
🌐 www.alembicpharmaceuticals.com ↗

📍 Alembic Road, Vadodara, Gujarat, 390003

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Apar Industries Ltd.Anjani Portland Cem Ltd.Apcotex Industries LimitedApex Frozen Foods LimitedApex Ecotech LimitedAPL Apollo Tubes Ltd.Apollo Micro Systems Ltd.Apollo Hospitals Enter. LimitedApollo Pipes LimitedApollo Tyres Ltd.Apollo Sindoori Hotel Ltd.Aprameya Engineering Ltd.All “A” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search